Pikeville Medical Center INC

Pikeville Medical Center INC was paid $181.38M by Medicaid between Jan 2018 and Dec 2024, across 733 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 7.7% of everything it billed.

33Billing provider infoPIKEVILLE MEDICAL CENTER INC
PIKEVILLE, KY 41501

33aNPI1285621623assigned 09/30/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$181.38M

24GClaims4,310,485

24DCodes billed733

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Kentucky

Rank by total paid#2 of 36

Median peer was paid$36.08M

This provider vs. median5.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	554,552	$22.90M
2019	554,744	$24.32M
2020	604,775	$26.38M
2021	668,580	$27.74M
2022	663,559	$26.14M
2023	683,990	$28.91M
2024incomplete	580,285	$24.99M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	7.7%	501,201	350,864	$14.03M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.9%	47,955	41,141	$8.88M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.8%	16,484	12,080	$8.64M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.4%	36,278	23,382	$7.90M
0202U	Oncology (prostate), multianalyte, gene expression profiling	3.0%	18,745	15,833	$5.53M
74176	Computed tomography, abdomen and pelvis; without contrast material	3.0%	13,722	9,663	$5.39M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.9%	41,834	36,641	$5.24M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.9%	11,722	9,975	$3.49M
70450	Computed tomography, head or brain; without contrast material	1.6%	15,765	11,543	$2.93M
G0378	Hospital observation service, per hour	1.5%	18,308	13,334	$2.80M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.5%	69,456	52,772	$2.78M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.5%	69,576	29,866	$2.71M

721 more codes

71275	Computed tomographic angiography, chest, with contrast material	1.5%	6,080	$2.69M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.3%	6,548	$2.34M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.2%	43,093	$2.21M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	31,569	$2.10M
59025	Fetal non-stress test	1.1%	9,383	$1.96M
20610		1.0%	13,455	$1.90M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	5,028	$1.75M
41899	Unlisted procedure, dentoalveolar structures	<1%	2,268	$1.74M
74178		<1%	2,861	$1.69M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	6,927	$1.69M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	4,888	$1.67M
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	19,320	$1.66M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	57,321	$1.56M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	3,848	$1.55M
96375	Therapeutic injection; each additional sequential IV push	<1%	42,619	$1.46M
96361	Intravenous infusion, hydration; each additional hour	<1%	42,960	$1.40M
80053	Comprehensive metabolic panel	<1%	115,210	$1.37M
71045	Radiologic examination, chest; single view	<1%	40,253	$1.36M
36415	Collection of venous blood by venipuncture	<1%	349,059	$1.31M
96376		<1%	26,855	$1.30M
72131		<1%	6,347	$1.30M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	13,094	$1.27M
47562		<1%	1,208	$1.23M
93017		<1%	3,911	$1.23M
71046	Radiologic examination, chest; 2 views	<1%	18,952	$1.12M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	25,426	$1.11M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	26,356	$1.10M
J7030	Infusion, normal saline solution , 1000 cc	<1%	48,600	$1.05M
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	24,559	$1.03M
72125	Computed tomography, cervical spine; without contrast material	<1%	5,845	$1.01M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,478	$1.01M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	9,957	$984K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	136,334	$926K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	17,981	$921K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,670	$916K
71250		<1%	6,387	$908K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	11,122	$865K
72141		<1%	2,763	$865K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	17,065	$856K
73630		<1%	12,012	$837K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	17,897	$833K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	6,879	$825K
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,401	$785K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,131	$775K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	7,139	$770K
76830	Ultrasound, transvaginal	<1%	6,142	$755K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	22,033	$726K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,117	$718K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,123	$680K
93971		<1%	3,502	$658K
73610		<1%	8,378	$656K
84443	Thyroid stimulating hormone (TSH)	<1%	46,095	$655K
72128		<1%	3,909	$654K
73560		<1%	10,580	$642K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	12,722	$632K
76770		<1%	3,036	$628K
93454		<1%	834	$602K
73030		<1%	8,487	$585K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	18,267	$581K
73221		<1%	1,492	$567K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,406	$561K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,890	$558K
93225		<1%	2,201	$537K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,007	$533K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,583	$530K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	16,616	$525K
73130		<1%	7,061	$524K
99213	Doctor's office visit, returning patient (routine)	<1%	12,161	$520K
93970		<1%	2,655	$502K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	5,973	$485K
76536		<1%	4,624	$480K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,869	$478K
94760		<1%	87,777	$466K
70486		<1%	1,996	$460K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,420	$453K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	564	$446K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	8,842	$441K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	18,942	$440K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,516	$437K
71270		<1%	1,957	$437K
73562		<1%	5,336	$418K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	6,954	$405K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,163	$399K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,020	$399K
80048	Basic metabolic panel (calcium, ionized)	<1%	50,653	$399K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,076	$380K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	4,411	$373K
80061	Lipid panel	<1%	33,274	$361K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	30,961	$346K
84484		<1%	28,142	$339K
73110		<1%	5,217	$338K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,564	$325K
70498		<1%	1,019	$322K
94726		<1%	2,035	$298K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	7,684	$293K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	987	$287K
82607		<1%	22,009	$282K
J7050	Infusion, normal saline solution, 250 cc	<1%	19,345	$274K
C1776	Joint device (implantable)	<1%	434	$274K
72100		<1%	4,346	$271K
70496		<1%	906	$265K
87902		<1%	1,305	$265K
83880		<1%	9,725	$246K
70492		<1%	639	$245K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,314	$243K
87086	Culture, bacterial; quantitative colony count, urine	<1%	32,888	$242K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	9,753	$239K
87581		<1%	7,361	$237K
87486		<1%	7,663	$223K
93922		<1%	1,643	$222K
93226		<1%	1,677	$222K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,616	$220K
85027		<1%	40,547	$220K
83036	Hemoglobin; glycosylated (A1C)	<1%	27,940	$218K
80074		<1%	6,761	$215K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,989	$214K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	5,285	$214K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,953	$209K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	10,096	$208K
88304		<1%	4,455	$207K
86235		<1%	3,828	$200K
J2704	Injection, propofol, 10 mg	<1%	23,644	$194K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	17,707	$188K
73590		<1%	3,034	$186K
95811		<1%	440	$186K
81001		<1%	59,254	$183K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	5,636	$179K
96415		<1%	1,295	$177K
73700		<1%	1,177	$177K
72170		<1%	3,419	$175K
J3490	Unclassified drugs	<1%	9,649	$167K
J1170	Injection, hydromorphone, up to 4 mg	<1%	12,641	$167K
74183		<1%	568	$167K
74018		<1%	2,960	$165K
10060		<1%	1,023	$164K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,081	$160K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	7,009	$159K
84145		<1%	8,387	$157K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	5,766	$156K
97153	Applied behavior analysis (autism therapy), per 15 minutes	<1%	3,923	$155K
73090		<1%	2,438	$152K
83605		<1%	16,811	$152K
84702		<1%	11,204	$151K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,034	$148K
76942		<1%	2,586	$147K
93880		<1%	2,409	$146K
87522	Neg quan hep c or qual rna	<1%	3,624	$146K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,827	$145K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,884	$144K
83690		<1%	22,365	$144K
73080		<1%	1,892	$141K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	7,019	$141K
72070		<1%	1,831	$138K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	241	$137K
52000		<1%	766	$136K
82652		<1%	4,632	$134K
80047		<1%	11,566	$132K
72040		<1%	2,216	$131K
83516		<1%	4,152	$128K
87507		<1%	477	$126K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	4,568	$125K
J3370	Injection, vancomycin hcl, 500 mg	<1%	6,378	$124K
82805		<1%	2,303	$123K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	269	$122K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	27,666	$121K
C1769	Guide wire	<1%	4,207	$119K
11045		<1%	374	$117K
77080		<1%	1,231	$115K
96367		<1%	10,299	$114K
72158		<1%	262	$114K
77066	Tomosynthesis, mammo	<1%	2,303	$114K
77386		<1%	604	$109K
84703		<1%	16,000	$109K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	12,229	$107K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	28,413	$107K
82962		<1%	16,154	$106K
83735		<1%	19,609	$106K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	26	$105K
72146		<1%	348	$105K
94729		<1%	1,897	$103K
84439		<1%	12,921	$102K
36592		<1%	6,607	$102K
80081		<1%	1,702	$100K
36600		<1%	3,699	$100K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	267	$98K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	4,791	$98K
84144		<1%	5,122	$98K
73502		<1%	6,986	$98K
78227		<1%	327	$97K
64415		<1%	662	$97K
87040		<1%	7,732	$96K
11043		<1%	753	$94K
82728		<1%	8,078	$94K
64447		<1%	813	$94K
83520		<1%	4,229	$94K
J1644	Injection, heparin sodium, per 1000 units	<1%	15,228	$93K
87077		<1%	13,160	$92K
82746		<1%	7,447	$92K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	4,239	$91K
76642		<1%	2,251	$90K
86850		<1%	9,114	$90K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	24,657	$90K
77336		<1%	1,236	$89K
94010		<1%	1,957	$88K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,106	$88K
85610		<1%	22,420	$87K
86140		<1%	19,226	$85K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	28,819	$84K
84403		<1%	3,806	$83K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,157	$83K
J0690	Injection, cefazolin sodium, 500 mg	<1%	12,121	$83K
95816		<1%	981	$82K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	3,568	$82K
0002A		<1%	4,992	$81K
80050	General health panel	<1%	2,316	$80K
69210		<1%	1,836	$80K
97162		<1%	5,072	$79K
93458		<1%	37	$79K
73100		<1%	1,333	$77K
83970		<1%	2,454	$77K
84425		<1%	4,241	$75K
83540		<1%	13,878	$75K
J1756	Injection, iron sucrose, 1 mg	<1%	477	$75K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	42,210	$75K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,663	$74K
87070		<1%	8,011	$74K
80076		<1%	9,940	$73K
97597		<1%	1,416	$73K
87186		<1%	9,445	$73K
95909		<1%	822	$72K
81025		<1%	9,505	$72K
29125		<1%	886	$72K
86038		<1%	6,959	$71K
99218		<1%	548	$71K
81003		<1%	22,942	$71K
97803		<1%	4,836	$71K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	535	$70K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	28,450	$70K
G0379	Direct admission of patient for hospital observation care	<1%	1,769	$70K
87430		<1%	4,564	$68K
51702		<1%	1,498	$68K
87634		<1%	1,095	$67K
94060		<1%	859	$67K
82105		<1%	4,024	$67K
78306		<1%	479	$66K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	2,806	$65K
85730		<1%	13,336	$62K
88342		<1%	1,412	$61K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	12,413	$61K
76000		<1%	1,163	$61K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	7,317	$61K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	403	$60K
78264		<1%	255	$58K
97010		<1%	3,375	$58K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,420	$57K
84207		<1%	2,392	$57K
0001A		<1%	5,142	$57K
93923		<1%	602	$55K
31575		<1%	1,184	$54K
86160		<1%	3,677	$54K
86480		<1%	1,087	$53K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,465	$53K
73060		<1%	922	$53K
74022		<1%	551	$53K
97535	Self-care/home management training, each 15 minutes	<1%	2,380	$51K
20551		<1%	726	$51K
99203	Doctor's office visit, new patient (routine)	<1%	1,056	$51K
76870		<1%	823	$50K
72110		<1%	500	$50K
99292		<1%	78	$50K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	457	$50K
83001		<1%	2,639	$48K
93925		<1%	436	$48K
80305		<1%	6,394	$48K
86147		<1%	1,100	$47K
84134		<1%	3,775	$47K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,354	$47K
86256		<1%	3,179	$46K
87481		<1%	921	$46K
84480		<1%	3,947	$45K
90715		<1%	3,757	$45K
82150		<1%	7,150	$45K
73070		<1%	719	$45K
86901		<1%	7,821	$45K
0353U		<1%	1,836	$44K
95806		<1%	758	$44K
C9113	Injection, pantoprazole sodium, per vial	<1%	5,253	$44K
11721		<1%	1,316	$43K
J0248	Injection, remdesivir, 1 mg	<1%	165	$43K
85652		<1%	15,687	$43K
82677		<1%	1,884	$43K
86376		<1%	3,368	$42K
92526		<1%	658	$41K
73120		<1%	645	$41K
90472	Immunization administration, each additional vaccine (list separately)	<1%	7,451	$41K
87899		<1%	1,439	$41K
84436		<1%	6,942	$41K
27447		<1%	141	$41K
83002		<1%	2,502	$41K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,837	$40K
77065	Tomosynthesis, mammo	<1%	1,655	$40K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,371	$40K
10005		<1%	206	$40K
82803		<1%	2,274	$39K
J1953	Injection, levetiracetam, 10 mg	<1%	533	$39K
82550		<1%	5,221	$39K
84466		<1%	4,104	$39K
86900		<1%	7,761	$39K
85379		<1%	4,505	$37K
93296		<1%	4,430	$37K
87340		<1%	4,642	$37K
12001		<1%	715	$37K
58300		<1%	536	$37K
82784		<1%	3,641	$36K
86762		<1%	3,197	$36K
97116		<1%	1,874	$36K
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	1,805	$35K
49083		<1%	237	$34K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	6,009	$34K
92523		<1%	543	$34K
97166		<1%	1,941	$34K
86200		<1%	3,474	$34K
20550		<1%	250	$33K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	5,681	$32K
84153		<1%	2,372	$32K
87081		<1%	3,569	$32K
86255		<1%	2,487	$31K
73552		<1%	1,809	$30K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,033	$30K
43235		<1%	108	$30K
86803		<1%	2,616	$30K
95886		<1%	929	$29K
73140		<1%	1,158	$29K
G0390	Trauma response team associated with hospital critical care service	<1%	43	$29K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	2,003	$28K
82239		<1%	1,897	$28K
81002		<1%	8,562	$28K
J0875	Injection, dalbavancin, 5 mg	<1%	12	$28K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	102	$28K
83615		<1%	4,949	$28K
98926		<1%	1,739	$27K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	840	$27K
86336		<1%	1,877	$27K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,643	$27K
86146		<1%	858	$26K
84146		<1%	1,551	$26K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	371	$25K
81514		<1%	381	$25K
86709		<1%	2,993	$25K
36430		<1%	166	$25K
J7070	Infusion, d5w, 1000 cc	<1%	1,176	$25K
73564		<1%	257	$25K
86225		<1%	2,467	$25K
52352		<1%	41	$25K
86320		<1%	1,026	$25K
84550		<1%	6,099	$25K
82330		<1%	2,330	$25K
86708		<1%	2,015	$25K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	205	$24K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,864	$24K
84100		<1%	6,382	$24K
88307		<1%	435	$24K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,195	$24K
73600		<1%	434	$24K
93308		<1%	290	$23K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	3,093	$23K
29824		<1%	115	$23K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,332	$23K
82378		<1%	1,415	$23K
73620		<1%	334	$23K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	1,339	$23K
82172		<1%	1,303	$23K
83883		<1%	1,589	$23K
86704		<1%	2,026	$23K
73521		<1%	905	$22K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	809	$22K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	5,425	$22K
77300		<1%	99	$22K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	420	$22K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,609	$21K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	955	$21K
84481		<1%	1,556	$21K
Q3014	Telehealth originating site facility fee	<1%	5,708	$21K
76857		<1%	142	$21K
J1956	Injection, levofloxacin, 250 mg	<1%	1,089	$20K
98927		<1%	1,268	$20K
29881		<1%	73	$20K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	4,348	$20K
72157		<1%	54	$20K
86706		<1%	1,788	$19K
82140		<1%	1,831	$19K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	91	$19K
74220		<1%	139	$19K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	600	$19K
86592		<1%	4,701	$19K
86618		<1%	791	$19K
96417		<1%	780	$19K
87493		<1%	619	$19K
64615		<1%	177	$18K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	3,561	$18K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	5,761	$18K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	2,308	$18K
82085		<1%	1,336	$17K
83655		<1%	1,467	$17K
72202		<1%	288	$17K
84402		<1%	862	$16K
97155	Adaptive behavior treatment with protocol modification, administered by physician, each 15 minutes	<1%	1,186	$16K
97161		<1%	779	$16K
86334		<1%	1,060	$16K
82951		<1%	1,278	$16K
74174		<1%	125	$16K
82248		<1%	3,421	$16K
96523		<1%	2,233	$16K
29879		<1%	53	$16K
83010		<1%	1,304	$16K
92557		<1%	367	$16K
72050		<1%	167	$16K
29425		<1%	280	$16K
84156		<1%	3,931	$15K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	88	$15K
83550		<1%	2,256	$15K
86317		<1%	1,303	$15K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	658	$15K
V2632	Posterior chamber intraocular lens	<1%	507	$15K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,540	$14K
82565		<1%	3,858	$14K
70491		<1%	57	$14K
81374		<1%	204	$14K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	13,894	$14K
82747		<1%	923	$14K
71271		<1%	662	$14K
85007		<1%	4,257	$13K
87807		<1%	1,048	$13K
J0736	Injection, clindamycin phosphate, 300 mg	<1%	504	$13K
11055		<1%	303	$13K
12002		<1%	149	$13K
77334		<1%	47	$12K
74240		<1%	106	$12K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	555	$12K
82360		<1%	765	$12K
86430		<1%	2,385	$12K
77002		<1%	252	$12K
82043		<1%	2,361	$12K
97802		<1%	502	$12K
88312		<1%	814	$12K
J0184	Injection, amisulpride, 1 mg	<1%	119	$12K
87075		<1%	1,212	$12K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,806	$11K
90746		<1%	625	$11K
82950		<1%	2,779	$11K
72156		<1%	35	$11K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	71	$11K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	693	$11K
82977		<1%	1,446	$11K
87045		<1%	1,237	$11K
80069		<1%	1,204	$11K
42821		<1%	16	$10K
84165		<1%	1,277	$10K
96130		<1%	183	$10K
73702		<1%	53	$10K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	29	$10K
97804		<1%	1,064	$10K
84132		<1%	2,348	$10K
80177		<1%	725	$9K
92567		<1%	577	$9K
76882		<1%	156	$9K
82103		<1%	788	$9K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	256	$9K
86431		<1%	2,156	$9K
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	323	$9K
90686		<1%	2,753	$9K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	131	$8K
87209		<1%	520	$8K
93270		<1%	621	$8K
82570		<1%	1,821	$8K
95249		<1%	500	$8K
11750		<1%	41	$8K
96131		<1%	182	$8K
81596		<1%	292	$8K
90670		<1%	3,072	$8K
86308		<1%	1,545	$8K
87800		<1%	297	$8K
90714		<1%	208	$8K
75635		<1%	48	$8K
83874		<1%	331	$8K
29880		<1%	31	$8K
73200		<1%	27	$8K
93312		<1%	17	$8K
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	429	$8K
0004A		<1%	1,046	$7K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	162	$7K
90633		<1%	2,066	$7K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	514	$7K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	12	$7K
82731		<1%	106	$7K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,132	$7K
90474		<1%	2,851	$7K
92083		<1%	270	$7K
82553		<1%	352	$7K
86665		<1%	209	$7K
76801		<1%	155	$6K
J1630	Injection, haloperidol, up to 5 mg	<1%	819	$6K
J1815	Injection, insulin, per 5 units	<1%	224	$6K
85018		<1%	2,838	$6K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	491	$6K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	19	$6K
93298		<1%	643	$6K
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	602	$6K
80202		<1%	704	$6K
64445		<1%	52	$6K
82390		<1%	646	$6K
82947		<1%	1,670	$5K
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	<1%	730	$5K
86705		<1%	474	$5K
86920		<1%	144	$5K
J2060	Injection, lorazepam, 2 mg	<1%	1,705	$5K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	55	$5K
76519		<1%	311	$5K
85045		<1%	1,500	$5K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	286	$5K
C1726	Catheter, balloon dilatation, non-vascular	<1%	28	$5K
83993		<1%	275	$5K
29826		<1%	127	$5K
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	263	$5K
83527		<1%	439	$5K
97035		<1%	148	$5K
72082		<1%	133	$5K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,210	$5K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	2,362	$5K
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	<1%	206	$4K
J3360	Injection, diazepam, up to 5 mg	<1%	243	$4K
87177		<1%	540	$4K
87538		<1%	174	$4K
87205		<1%	1,357	$4K
90688		<1%	1,442	$4K
17110		<1%	67	$4K
96368		<1%	321	$4K
98925		<1%	265	$4K
36416		<1%	2,496	$4K
83921		<1%	303	$4K
99152		<1%	129	$4K
L4387	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf	<1%	200	$4K
87535		<1%	172	$4K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	103	$4K
83525		<1%	401	$4K
84450		<1%	1,001	$4K
82787		<1%	658	$4K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	126	$4K
84460		<1%	953	$4K
A4565	Slings	<1%	1,760	$4K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	114	$4K
29515		<1%	49	$4K
93299		<1%	364	$4K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	100	$4K
77280		<1%	106	$4K
11102		<1%	61	$4K
94667		<1%	165	$4K
57500		<1%	13	$4K
J1940	Injection, furosemide, up to 20 mg	<1%	879	$4K
93280		<1%	548	$4K
87517		<1%	96	$3K
97151		<1%	253	$3K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	13	$3K
84295		<1%	434	$3K
A9561	Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	<1%	34	$3K
C1758	Catheter, ureteral	<1%	306	$3K
11056		<1%	125	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,586	$3K
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	98	$3K
90632		<1%	303	$3K
76775		<1%	63	$3K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	32	$3K
73000		<1%	78	$3K
88313		<1%	158	$3K
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	1,144	$3K
88341		<1%	81	$3K
0012A		<1%	216	$3K
29876		<1%	40	$3K
86580		<1%	367	$3K
C2618	Probe/needle, cryoablation	<1%	118	$3K
58100		<1%	14	$3K
90680		<1%	2,677	$2K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	151	$2K
86617		<1%	220	$2K
75574		<1%	15	$2K
12011		<1%	39	$2K
29130		<1%	55	$2K
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	141	$2K
86300		<1%	141	$2K
82247		<1%	488	$2K
95819		<1%	48	$2K
90677		<1%	627	$2K
82533		<1%	147	$2K
82164		<1%	70	$2K
71101		<1%	32	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	109	$2K
82785		<1%	86	$2K
85014		<1%	1,136	$2K
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	151	$2K
85384		<1%	244	$2K
84445		<1%	42	$2K
90647		<1%	2,969	$2K
94668		<1%	35	$2K
86703		<1%	178	$2K
E0114	Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips	<1%	150	$2K
25600		<1%	14	$2K
29075		<1%	27	$2K
90700		<1%	552	$2K
51798		<1%	53	$2K
97163		<1%	250	$2K
90832	Psychotherapy session, about 30 minutes	<1%	69	$2K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	965	$2K
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	113	$1K
84479		<1%	386	$1K
90723		<1%	3,023	$1K
90649		<1%	138	$1K
97156		<1%	156	$1K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	50	$1K
58301		<1%	14	$1K
0011A		<1%	191	$1K
J2470	Injection, pantoprazole sodium, 40 mg	<1%	208	$1K
72072		<1%	12	$1K
93291		<1%	102	$1K
86664		<1%	86	$1K
84432		<1%	80	$1K
80171		<1%	57	$1K
94664		<1%	73	$1K
82010		<1%	195	$1K
84630		<1%	130	$1K
86663		<1%	84	$1K
82272		<1%	327	$983.94
85732		<1%	252	$982.30
0003A		<1%	118	$939.63
76937		<1%	145	$928.14
82525		<1%	95	$917.03
A4649	Surgical supply; miscellaneous	<1%	366	$910.50
86738		<1%	55	$907.80
G0010	Administration of hepatitis b vaccine	<1%	46	$903.36
0071A		<1%	135	$888.41
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	25	$885.69
76641		<1%	12	$885.18
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	163	$852.61
87329		<1%	74	$837.65
90707		<1%	395	$821.88
94761		<1%	109	$820.37
0072A		<1%	109	$797.48
80323		<1%	31	$784.46
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	34	$781.76
94618		<1%	41	$777.20
J1171	Injection, hydromorphone, 0.1 mg	<1%	190	$775.42
97018		<1%	37	$775.00
99219		<1%	43	$766.59
86769		<1%	19	$736.38
93271		<1%	15	$707.67
87449		<1%	68	$651.84
98928		<1%	30	$642.06
C1729	Catheter, drainage	<1%	56	$609.56
86800		<1%	49	$603.13
J0694	Injection, cefoxitin sodium, 1 gm	<1%	40	$602.02
A9270	Non-covered item or service	<1%	6,264	$593.19
82009		<1%	124	$588.95
86304		<1%	42	$564.27
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	40	$527.12
90734		<1%	363	$494.70
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	16	$494.47
J3411	Injection, thiamine hcl, 100 mg	<1%	64	$462.96
92136		<1%	16	$453.39
81015		<1%	1,017	$449.85
80164		<1%	38	$447.65
82552		<1%	40	$445.92
90716		<1%	344	$420.20
G0008	Administration of influenza virus vaccine	<1%	62	$411.06
90671		<1%	244	$395.75
90710		<1%	593	$358.45
84446		<1%	29	$351.42
86682		<1%	41	$349.45
97167		<1%	36	$347.14
83825		<1%	29	$345.13
82040		<1%	223	$344.76
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	963	$332.86
90658		<1%	139	$331.67
82175		<1%	29	$326.73
87210		<1%	60	$326.34
90651		<1%	121	$323.19
82948		<1%	172	$321.80
82670		<1%	13	$311.26
36591		<1%	39	$282.02
86301		<1%	17	$270.13
84520		<1%	133	$265.70
90655		<1%	106	$264.85
82705		<1%	72	$256.37
90685		<1%	662	$252.52
85300		<1%	36	$235.38
82435		<1%	32	$210.97
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	311	$199.92
97168		<1%	15	$191.22
84155		<1%	109	$188.33
84442		<1%	14	$177.38
87425		<1%	13	$170.09
82952		<1%	84	$158.21
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	43	$153.87
84590		<1%	13	$150.69
86593		<1%	39	$150.15
87101		<1%	21	$149.28
80185		<1%	18	$133.10
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	28	$114.88
90696		<1%	265	$108.73
85302		<1%	16	$107.61
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	19	$107.23
87324		<1%	30	$106.62
J7510	Prednisolone oral, per 5 mg	<1%	49	$97.60
84075		<1%	25	$94.24
85613		<1%	16	$87.36
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	18	$86.17
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	108	$67.92
85670		<1%	12	$46.88
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	89	$36.09
85049		<1%	20	$23.36
90653		<1%	43	$11.82
90620		0%	33	$0.00
29823		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAGY, MICHELLE (CFO)

Same official

Other billing entities under HAGY, MICHELLE

Full network →

Provider	Location	Paid
Pikeville Medical Center INC.	Pikeville, KY	$34.42M
Pikeville Medical Center INC.	Pikeville, KY	$1.25M
Pikeville Medical Center INC.	Pikeville, KY	$809K
Pikeville Medical Center, INC. (Pikeville Family Practice Clinic)	Pikeville, KY	$424K
Pikeville Medical Center INC	Pikeville, KY	$160K
Pikeville Medical Center INC	Pikeville, KY	$155K
Pikeville Medical Center, INC.	Pikeville, KY	$62K
Pikeville Medical Center, INC.	Grundy, VA	$749.26
Pikeville Medical Center, INC.	Pikeville, KY	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.